RESUMO
INTRODUCTION: Fever of unknown origin (FUO) is one of the most difficult diagnostic dilemmas in current medicine. The main causes of FUO in developed countries are non-infectious inflammatory diseases, while infections are predominant in developing countries. Among infections, Mycobacterium Tuberculosis (TB) is the most frequent cause and it can involve multiple tissues and organs. CASE AND OUTCOMES: We report a case of FUO in an immunocompetent patient with fever of unknown origin, finally diagnosed with skeletal TB thanks to a multidisciplinary approach, using FDG-PET/CT, MRI, and biopsy. PET/CT findings were non-specific (infection or inflammation versus malignancy); therefore, hip Magnetic Resonance Imaging (MRI) was performed and infection was suspected on basis of MRI findings, so a bone biopsy was then performed and skeletal TB was diagnosed. DISCUSSION: A successful diagnostic workup of FUO has to take into account detailed medical history, physical examination, laboratory tests, blood and urine cultures, and standard imaging (Ultrasonography, CT, or MRI). However, this combination of clinical evaluation, standardized laboratory tests and simple imaging procedures often do not lead to a definite diagnosis; 8F-FDG-PET-CT could be performed to help in diagnosis and also to guide additional diagnostic tests such as MRI and biopsy. CONCLUSION: This case demonstrates the importance of the integration of different imaging modalities, in particular, MRI and FDG-PET/CT in patients with FUO. Skeletal TB should always be included in the diagnostic hypothesis of FUO, even in immunocompetent patients of non-endemic countries.
Assuntos
Febre de Causa Desconhecida , Tuberculose , Febre de Causa Desconhecida/diagnóstico por imagem , Febre de Causa Desconhecida/etiologia , Fluordesoxiglucose F18 , Humanos , Imageamento por Ressonância Magnética/efeitos adversos , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada/métodos , Tuberculose/complicaçõesAssuntos
COVID-19/epidemiologia , Infecções por HIV/tratamento farmacológico , Fármacos Anti-HIV/administração & dosagem , Fármacos Anti-HIV/uso terapêutico , COVID-19/complicações , COVID-19/virologia , Infecções por HIV/complicações , Humanos , Masculino , Pessoa de Meia-Idade , SARS-CoV-2/isolamento & purificaçãoRESUMO
We report a case of a 13-year-old immunocompetent male with multifocal tubercular osteomyelitis involving several spinal segments, small bones of the hands, and the scalp, who started with progressively back pain and enlarging painful swelling on the palms of hands, fatigue, and irregular fever. All the hand lesions were firm, mildly tender, and covered by ulcerated skin with serous discharge from the site. Magnetic resonance showed lesions of the right fifth metacarpal, of the right intermediate phalanx of the fourth finger, of the left second metacarpal, and of most vertebral bodies of the cervical, dorsal, lumbar, and sacral spine. The nucleic acid amplification test and the final culture from the drainage of the hands' lesion were positive for Mycobacterium tuberculosis. The patient received a standard antitubercular treatment for 12 months with clinical improvement.
Assuntos
Osteomielite/diagnóstico por imagem , Tuberculose/complicações , Tuberculose/diagnóstico por imagem , Adolescente , Antituberculosos/uso terapêutico , Mãos/microbiologia , Mãos/patologia , Humanos , Imunocompetência , Masculino , Mycobacterium tuberculosis/genética , Osteomielite/microbiologia , Couro Cabeludo/microbiologia , Couro Cabeludo/patologia , Coluna Vertebral/microbiologia , Coluna Vertebral/patologia , Tuberculose/tratamento farmacológicoRESUMO
PURPOSE: Mycobacterium abscessus, and rapidly growing mycobacteria in general, are rare but increasing causes of central nervous system (CNS) infections. The aim of this study is to highlight the importance of considering these microorganism in the differential diagnosis of CNS infections, obtaining a prompt diagnosis, and improving clinical outcomes. METHODS: Case report and literature review. RESULTS: We report a case of meningeal infection in a patient who underwent decompressive craniectomy after a craniofacial trauma. The diagnosis was made analyzing a sample obtained during a second operation of cranioplasty. A regimen of amikacin, clarithromycin, and imipenem/cilastatin was started. In the following days, the patient experienced a variety of side effects. So, first clarithromycin was replaced with linezolid, then amikacin was stopped and cefoxitin added to the therapy and at the end all the antibiotics were withdrawn. The patient was discharged in good conditions and a clinical interdisciplinary follow-up was started. After 12 months, the patient is still doing well. After a literature analysis, 15 cases of M. abscessus CNS infections were identified. Various modes of acquisition, underlying disease and therapeutic schemes were evident. CONCLUSIONS: Considering the results of the literature analysis and the increasing incidence of M. abscessus, all specialists involved in the management of CNS infection should be aware of the importance of atypical microorganisms in differential diagnosis.
Assuntos
Achados Incidentais , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Mycobacterium abscessus , Tuberculose Meníngea/diagnóstico , Proteínas de Bactérias/genética , Chaperonina 60/genética , Escala de Coma de Glasgow , Hematoma Subdural Agudo/complicações , Hematoma Subdural Agudo/diagnóstico , Humanos , Período Intraoperatório , Masculino , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/complicações , Infecções por Mycobacterium não Tuberculosas/microbiologia , Mycobacterium abscessus/genética , Reação em Cadeia da Polimerase , Tomografia Computadorizada por Raios X , Tuberculose Meníngea/complicações , Tuberculose Meníngea/microbiologiaAssuntos
Infestações por Piolhos/terapia , Refugiados/psicologia , Síndrome do Desconforto Respiratório/terapia , Recusa do Paciente ao Tratamento/psicologia , Adolescente , África Oriental/etnologia , Borrelia/patogenicidade , Infecções por Borrelia/psicologia , Infecções por Borrelia/terapia , Feminino , Humanos , Hipotensão/etiologia , Itália , Icterícia/etiologia , Leptospira/patogenicidade , Leptospirose/psicologia , Leptospirose/terapia , Infestações por Piolhos/psicologia , Síndrome do Desconforto Respiratório/etnologia , Síndrome do Desconforto Respiratório/psicologia , Recusa do Paciente ao Tratamento/etnologiaRESUMO
INTRODUCTION: According to recent evidence about boosted protease inhibitors (PIs/r)-simplified regimens, the combination of 3TC and DRV/r 800/100 mg could represent a feasible option for optimizing antiretroviral therapy (ART) in treatment-experienced HIV+ patients. PATIENTS AND METHODS: We retrospectively evaluated patients switching to 3TC+DRV/r, with at least six months of viral suppression, no resistance mutation to DRV or 3TC and not HBV-coinfected: incidence of ART discontinuation and of virological failure (VF: 2 consecutive HIV-RNA determinations>49 cps/mL or a single one≥1000 cps/mL) and the probability of remaining discontinuation-free during one-year follow-up (FU), as well as changes in laboratory parameters at 1, 3, 6 and 12 months were estimated. RESULTS: We included 94 patients: 74 males, mostly MSM (39.4%), with 49 years old, 9 years of HIV disease, 8 years of ART (median values). Median nadir CD4 count and zenith viral load (log10) were 194 cells/µL and 4.90, respectively. Ten patients were HCV-coinfected and 38 had at least a previous VF. Seventy-four patients were on an NRTIs-based triple regimen (mainly TDF/FTC or 3TC/ABC) whereas 14 on another PI-based dual therapy (mainly LPV/r). Incidence of treatment discontinuation was 12.4 per 100 patients-year follow-up (PYFU), but only 2 patients experienced a VF (3.5 per 100 PYFU). Mean time free from discontinuation was 5 years (95% CI 4-6), with a cumulative one-year estimated probability of staying on 3TC+DRV/r of 85.9%. At three months, a trend of increased CD4 cells count (+42 cells/µL, p 0.059) was observed, but not confirmed at later time point; an increase of total cholesterol (TC, +17mg/dL, p 0.008) and LDL (+19 mg/dL, p 0.002), and a decreased level of AST and ALT (-2 UI/L, p 0.045; -5 UI/L, p 0.009, respectively) were also detected. Total bilirubin was reduced (-0.71 mg/dL, p 0.038). At 6 and 12 months, alteration of lipid profile was similar, with also an increased TC/HDL ratio (+0.48, p=0.030, at six months) and HDL/LDL ratio (-0.04, p=0.035, at 12 months). A significant decrease in ALT levels (-6 UI/L, 0.013) and a diminishing trend for AST and total bilirubin, as well as a significant increase in renal function (GFR +4mL/min, p 0.048) were observed at 12 months. CONCLUSIONS: These observations on 3TC+DRV/r-based dual therapy simplification in virologically suppressed patients show a good profile of efficacy and safety. An extended FU time is needed in order to establish the real impact of this promising therapeutic choice.
RESUMO
INTRODUCTION: Ageing of HIV-infected patients led to an increasing rate of osteopenia and osteoporosis. The cause is multifactorial, including virus activity, drug toxicity and host factors. The aim of our analysis is to quantify this issue according to our department experience and to evaluate predictors of low BMD. MATERIALS AND METHODS: HIV-1-infected patients, on stable HAART, were consecutively enrolled in this cross-sectional study and underwent DEXA. We analyzed the prevalence and evaluated predictors of low BMD in our population. RESULTS: We collected data from 208 patients, 148 of whom were male, with 49 years median age (IQR 24.1-68.3). About 39% of patients were heterosexuals, 33.7 MSM and 12.5% were IDU, 40.4% were smokers. Caucasians were 93.3%, and 13.9% were co-infected with HCV virus. Around 6.7% of patients were on their first HAART regimen and all of them started TDF. Their median time of HAART exposure was 1.17 years (IQR 0.8-1.6). Conversely, median time of HAART exposure of multi-experienced patients was 8.5 years (IQR 3.1-12.0). We stratified DEXA results for patients on first-line regimen versus multi-experienced one. We found that 42.9% of patients on first-line HAART had low BMD of lumbar spine and 7.1% had osteoporosis. Regarding the multi-experienced group of patients, lumbar spine osteopenia was observed in 36.6% of patients and 15.5% of them had osteoporosis. Median age of patients with low BMD of lumbar spine was 45.6 (IQR 24.1-68.3) for patients on first-line regimen and 49.8 years for multi-experienced (IQR 44.2-54.0) regimen. We found similar data for BMD of hip, but no patients in the first group had hip osteoporosis. We also analyzed predictors of low BMD in our population. MSM patients showed a 3.4-fold higher risk to have osteoporosis of lumbar spine (OR 3.41, CI 1,105-9,269, p=0.03). As expected, we found that non-Caucasian patients had 13.5-fold higher risk to have osteoporosis of the hip (OR 13.52, CI 1.5-122.7, p=0.02). Exposure to HAART was also evaluated, but no predictors were found. CONCLUSIONS: Our data confirm how osteoporosis is highly prevalent and occurs earlier in HIV-infected patients. Antiretrovirals play a crucial role. In our experience loss of BMD can occur within a year of treatment, when almost half of our patients starting TDF had a low BMD. MSM patients have a higher risk to develop spine osteoporosis and non-Caucasian patients are more likely to have hip osteoporosis. We remark the importance of BMD assessment for HIV-infected patients especially during their first months of treatment.
RESUMO
BACKGROUND: Changes in plasma uric acid concentration (UA, mumol/L) in postoperative and critical illness have pathophysiological and clinical relevance and may alter plasma antioxidant capacity. This issue is poorly understood because UA is simultaneously affected by multiple factors with impacts that have never been definitively characterized. METHODS: Data from 1050 measurements of UA and additional variables obtained in 151 patients were processed using regression analysis. RESULTS: The main direct correlate of UA was plasma creatinine (Cr), even in the absence of renal failure. UA was also related directly to sodium, glucose, cholesterol, albumin and other variables, and inversely to bilirubin. Postoperatively UA decreased, remaining related to preoperative UA and decreasing further with sepsis. In parenterally fed patients, UA was also inversely related to the amino acid dose. The following best fit explained three-quarters of its variability: UA=85.0(ln Cr, micromol/L)+0.6(preoperative UA)+4.3 (sodium, mmol/L)+5.4(glucose, mmol/L)-0.2(bilirubin, micromol/L)-28.9(amino acid dose, g/kg/day)-935.6; n=231, r(2)=0.74, p<0.0001. A contribution of extremely low UA to impaired plasma antioxidant capacity was suggested in severe sepsis. CONCLUSIONS: These data show the combined effect of several factors on UA. The results may help to evaluate changes in UA in the clinical setting and pathophysiological events related to oxidative stress, and provide evidence of impaired plasma antioxidant capacity in severe sepsis.
Assuntos
Nefropatias/diagnóstico , Nefropatias/metabolismo , Ácido Úrico/sangue , Ácido Úrico/metabolismo , Idoso , Albuminas/metabolismo , Antioxidantes/metabolismo , Análise Química do Sangue/métodos , Colestase/metabolismo , Estado Terminal , Feminino , Humanos , Rim/metabolismo , Masculino , Pessoa de Meia-Idade , Modelos Biológicos , Estudos Prospectivos , Análise de Regressão , Reprodutibilidade dos TestesRESUMO
An unusual cause of acute-onset and progressively worsening visual loss is presented. A 60-year-old woman was referred for left homonymous hemianopsia to our Emergency Medicine Department because of a suspected vascular accident. Ten years earlier she had been diagnosed as having chronic lymphocytic leukemia. Brain computed tomography and magnetic resonance imaging revealed "bilateral foci of white matter abnormalities in the occipital regions, compatible with a diagnosis of progressive multifocal leukoencephalopathy". Her cerebrospinal fluid was positive for papovavirus JC. Progressive multifocal leukoencephalopathy due to papovavirus JC, a typical complication in AIDS patients, is a rare complication in patients with other immunosuppressive conditions, such as chronic lymphocytic leukemia.
Assuntos
Cegueira/etiologia , Hemianopsia/etiologia , Leucemia Linfocítica Crônica de Células B/complicações , Leucoencefalopatia Multifocal Progressiva/diagnóstico , Síndrome da Imunodeficiência Adquirida/complicações , Encéfalo/diagnóstico por imagem , Feminino , Humanos , Leucemia Linfocítica Crônica de Células B/tratamento farmacológico , Leucoencefalopatia Multifocal Progressiva/diagnóstico por imagem , Leucoencefalopatia Multifocal Progressiva/etiologia , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Fatores de Tempo , Tomografia Computadorizada por Raios XRESUMO
To assess the incidence of nosocomial bloodstream infections (NBSIs) in human immunodeficiency virus (HIV)-infected patients, and to analyze the main associated risk factors, we performed a 1-year multicenter prospective study of patients with advanced HIV infection who were consecutively admitted to 17 Italian infectious diseases wards. As of May 1999, a total of 65 NBSIs (4.7%) occurred in 1379 admissions, for an incidence of 2.45 NBSIs per 1000 patient-days. Twenty-nine NBSIs were catheter-related bloodstream infections, with a rate of 9.6 central venous catheter-associated infections per 1000 device-days. Multivariate analysis indicated that variables independently associated with NBSIs included active injection drug use, a Karnofsky Performance Status score of <40, presence of a central venous catheter, and length of hospital stay. Mortality rates were 24.6% and 7.2% among patients with and without NBSIs, respectively (P<.00001). In the era of highly active antiretroviral therapy, NBSIs continue to occur frequently and remain severe and life-threatening manifestations.